Cardio Diagnostics, Inc.

Epi+Gen CHD™ is a clinical test that assesses your three-year risk of experiencing a coronary heart disease event, such as a heart attack.

Epi+Gen CHD™ may be right for you if:

You are between 35 and 75 years old
You have not been diagnosed with coronary heart disease
You have not had a heart attack or any cardiac operation
You have not experienced angina (pain, heaviness, or discomfort in the chest, arm, jaw, or shoulder, especially with exertion)
You have not had a bone marrow transplant

Epi+Gen CHD™ is $350

PrecisionCHD™ is a clinical test that aids in the diagnosis and management of coronary heart disease, the most common type of heart disease and the primary cause of heart attacks.

PrecisionCHD™ may be right for you if:

You are between 35 and 80 years old
You have signs or symptoms indicative of coronary heart disease
You have not had a bone marrow transplant

PrecisionCHD™ is $850

The cost of the test may be reimbursed by your FSA/HSA, contact your individual FSA/HSA for more information.

Request a Test Via Telemedicine

Request a test online through our telemedicine partner. If a provider orders a test, you will receive a lancet-based kit to collect your blood sample at home.

Tests are not available for patients in New York.

Frequently Asked Questions

Depending on where you are in your health journey, one test may be more appropriate for you than the other.

Epi+Gen CHD™ is a risk assessment test that identifies your likelihood of experiencing a coronary heart disease event, including a heart attack in the next three years. This test is intended for those who do not currently have signs or symptoms indicative of heart disease. Epi+Gen CHD™ is not intended for those who've had a heart attack or cardiac operation or experienced chest pain (especially with exertion) and those who have had a bone marrow transplant.

PrecisionCHD™ is a diagnostic test, meaning it's meant to help identify those who have coronary heart disease. If you have signs and symptoms indicative of heart disease or have been previously identified as being at high risk of developing heart disease, PrecisionCHD™ may be right for you. PrecisionCHD™ is not intended for those who have had a bone marrow transplant.

Ultimately, a licensed healthcare provider will determine if the test you requested is right for you based on all available information including your medical history, presence of risk factors and any signs or symptoms.

Epi+Gen CHD™ and PrecisionCHD™ both evaluate a panel of epigenetic and genetic biomarkers with artificial intelligence. Genetics accounts for your inherited risk of developing heart disease whereas epigenetics captures your acquired risk due to lifestyle and environmental factors. AI is able to interpret the patterns and complex interactions between your biomarkers. By integrating epigenetics, genetics, and AI, Cardio Diagnostics' tests assess your cardiovascular health unlike any other tool available today.

Epi+Gen CHD™ is $350 and PrecisionCHD™ is $850. Patients may be able to use FSA/HSA funds to pay for the tests.

Cardio Diagnostics' tests are prescription only. Patients can request a test via our telehealth partner here and a provider will determine if the test you requested is right for you.

Once a test is ordered by a provider, your sample collection kit will be shipped directly to your home and includes all the materials needed for collection and return of your blood sample. Inside, you’ll find finger lancets and a collection tube to obtain your blood sample, along with a return bag and a shipping label. After collecting your sample, place it in the return bag, attach the label, and drop off your package at any FedEx location.